(24/7 MARKET NEWS)– scPharmaceuticals Inc. (Nasdaq: SCPH) announced this morning that it entered into a binding term sheet for a $100 million secured debt facility managed by Oaktree Capital Management, with funds to be used to facilitate U.S. commercial launch of FUROSCIX(R).
scPharmaceuticals is at $4.70, down $0.28 (-5.62%), on 2 million shares traded.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.